A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma
Clinical trial NCT02951819 · COMPLETED
Trial details
- NCT number
- NCT02951819
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-09
- Primary completion
- 2018-03-08
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.